Researchers tackle cll, diabetes and trauma-hemorrhage - molecular medicine, a bi-monthly journal

Source: Lymphoma / Leukemia News From Medical News Today - Tuesday, November 18, 2008

Cv technologies inc.: world's top cancer research body sponsors landmark cold-fx(r) trial

Source: Market Wire - Pharmaceuticals and Biotech - Monday, November 17, 2008

Vaccination history and risk of non-hodgkin lymphoma: a population-based, case–control study

Source: Cancer Causes and Control - Sunday, November 16, 2008

Researchers tackle cll, diabetes and trauma-hemorrhage

Source: PRWeb: Medical Pharmaceuticals - Friday, November 14, 2008

Chronic lymphocytic leukemia (cll) cells genetically modified to express b7-1, icam-1, and lfa-3 confer apc capacity to t cells from cll patients

Source: Cancer Immunology, Immunotherapy - Thursday, November 13, 2008

Coexistent chronic lymphocytic leukemia and polycythemia vera requiring no treatment

Source: Medical Oncology - Thursday, November 13, 2008

Studies on monoclonal anti-isotypic and anti-idiotypic antibodies against leukemia and myeloma: i. preparation and characteristics of monoclonal anti-isotypic antibodies to igm from b chronic lymphocytic leukemia

Source: Journal of Huazhong University of Science and Technology -- Medical Sciences -- - Thursday, November 13, 2008

Caspase-independent type iii pcd: a new means to modulate cell death in chronic lymphocytic leukemia

Source: Leukemia - Wednesday, November 12, 2008

Genmab a/s: ofatumumab pivotal cll data to be presented at ash

Source: Lymphoma / Leukemia News From Medical News Today - Monday, November 10, 2008

Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory b-cell chronic lymphocytic leukemia.

Source: Haematologica - Sunday, November 09, 2008

[first-line therapy of chronic lymphocytic leukemia in the elderly: be careful with overtreatment.]

Source: Presse Medicale - Sunday, November 09, 2008

Case report and literature review: a rare patient with chronic myeloid leukemia and chronic lymphocytic leukemia.

Source: Annals of Clinical and Laboratory Science - Saturday, November 08, 2008

Fcrl6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with b-cell chronic lymphocytic leukemia.

Source: European Journal of Immunology - Thursday, November 06, 2008

Overexpression of toso in cll is triggered by b-cell receptor signaling and associated with progressive disease

Source: Blood - Wednesday, November 05, 2008

A prospective study of mitochondrial dna copy number and risk of non-hodgkin lymphoma

Source: Blood - Wednesday, November 05, 2008

[diagnosis in oncology] chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab

Source: Journal of Clinical Oncology - Wednesday, November 05, 2008

Treatment of b-cell chronic lymphocytic leukemia with nonchemotherapeutic agents: experience with single-agent and combination therapy

Source: Leukemia - Wednesday, November 05, 2008

Correspondence: monoclonal b-cell lymphocytosis and chronic lymphocytic leukemia

Source: New England Journal of Medicine - Tuesday, November 04, 2008

Novel leukemia vaccine for high-risk patients studied at moores ucsd cancer center

Source: Genetics News From Medical News Today - Tuesday, November 04, 2008

Small lymphocytic lymphoma/chronic lymphocytic leukemia in a pelvic myelolipoma.

Source: International Journal of Clinical and Experimental Pathology - Sunday, November 02, 2008

Pitfalls in diagnostic hematopathology: part i.

Source: International Journal of Clinical and Experimental Pathology - Sunday, November 02, 2008

Bendamustine is effective in p53-deficient b-cell neoplasms and requires oxidative stress and caspase-independent signaling.

Source: Clinical Cancer Research - Friday, October 31, 2008

Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation.

Source: Molecular Medicine - Friday, October 31, 2008

Ionizing radiation and risk of chronic lymphocytic leukemia in the 15-country study of nuclear industry workers.

Source: Radiation Research - Friday, October 31, 2008

[leukemia and bone marrow transplantation] allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective european group for blood and marrow transplantation analysis

Source: Journal of Clinical Oncology - Wednesday, October 29, 2008

Gemin x pan bcl-2 inhibitor obatoclax shows biological, clinical activity in heavily pre-treated patients with advanced chronic lymphocytic leukemia

Source: Lymphoma / Leukemia News From Medical News Today - Wednesday, October 29, 2008

The effect of in vivo t cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.

Source: Biology of Blood and Marrow Transplantation - Friday, October 24, 2008

Il-24 induces apoptosis of chronic lymphocytic leukemia b cells engaged into the cell cycle through dephosphorylation of stat3 and stabilization of p53 expression.

Source: Journal of Immunology - Friday, October 24, 2008

P2x7 gene polymorphisms do not appear to be a susceptibility gene locus in sporadic cases of systemic lupus erythematosus.

Source: Tissue Antigens - Thursday, October 23, 2008

Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers

Source: Blood - Wednesday, October 22, 2008

P53-mediated apoptosis of cll cells: evidence for a transcription-independent mechanism

Source: Blood - Wednesday, October 22, 2008

Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib

Source: Blood - Wednesday, October 22, 2008

Leukemia drug may benefit multiple sclerosis patients

Source: MedPage Today Neurology - Wednesday, October 22, 2008

Identification of tigar in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells.

Source: Haematologica - Tuesday, October 21, 2008